A
Altimmune, Inc.
ALT · NASDAQ · Healthcare · 572M
Closing price
$2.61
+0.38% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.0×
Enterprise value / EBITDAEV/EBITDA
-2.5×
Free cash flow yieldFCF yield
-29.4%
Return on equityROE
-39.2%
Operating margin
-230461.0%
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
-57.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.